Histogen Inc
Biotechnology
Healthcare
HSTO
3.55 M shares
NASDAQ US
traded
21 Mar 2023
listed
yes
open
1.29
52 week high
3.76
high
1.44
52 week low
1.32
low
1.29
growth
-45.78 %
previous Close
1.41
P/E ratio
-1
market cap
4.61 M
div yield
0
usd
Sep 2022
qoq
revenue
5.00 K
0.00 %
net incoming
-3.60 M
7.22 %
eps
-1.01 %
34.84 %
eps surprise
19.84 %
net profit margin
-71920.00 %
56.00 %
operating incoming
-3.60 M
-6.01 %
net change in cash
1.95 M
137.22 %
cash on hand
14.55 M
15.51 %
cost of revenue
0.00 %
top top